Efficacy of early angiotensin receptor/neprilysin inhibition in post-myocardial infarction patients: a meta-analysis of randomized controlled trials

Back

ESC Professional Premium Access

Efficacy of early angiotensin receptor/neprilysin inhibition in post-myocardial infarction patients: a meta-analysis of randomized controlled trials

Session: Heart failure therapy across the spectrum

Topic: Pharmacotherapy

Speaker: Associate Professor C. Hsu (Taipei, TW)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Associate Professor Chien-Yi Hsu

Taipei Medical University Hospital, Taipei (Taiwan)

0 follower

5 more presentations in this session

Empagliflozin versus dapagliflozin in heart failure

Speaker: Mr K. Bonnesen (Copenhagen, DK)

Early diagnosis of Wild-type Transthyretin Amyloidosis Cardiomyopathy by optimized screening of patients undergoing Carpal Tunnel Syndrome Surgery (CACTuS II)

Speaker: Mrs S. Fensman (Aarhus N, DK)

Home-based rehabilitation in patients with chronic heart failure after acute decompensation: primary results of the PILOT-CRHF trial

Speaker: Doctor A. Reuser (Leipzig, DE)

Remote rapid titration of heart failure therapies

Speaker: Doctor A. Abdel-Gadir (London, GB)

Short- and long-term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure

Speaker: Doctor V. Bytyqi (Erlangen, DE)

Access the full session

Heart failure therapy across the spectrum

Speakers: Associate Professor C. Hsu, Mr K. Bonnesen, Mrs S. Fensman, Doctor A. Reuser, Doctor A. Abdel-Gadir...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources